Your browser doesn't support javascript.
loading
Alamandine Induces Neuroprotection in Ischemic Stroke Models.
Gonçalves, Sthéfanie C A; Bassi, Beatriz L T; Kangussu, Lucas M; Alves, Daniele T; Ramos, Lorena K S; Fernandes, Lorena F; Alves, Marco T R; Sinisterra, Ruben; Bruch, Gisele E; Santos, Robson A S; Massensini, André R; Campagnole-Santos, Maria J.
Afiliación
  • Gonçalves SCA; National Institute of Science and Technology in Nanobiopharmaceutics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
  • Bassi BLT; Neuroscience Center, Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
  • Kangussu LM; Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
  • Alves DT; National Institute of Science and Technology in Nanobiopharmaceutics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
  • Ramos LKS; National Institute of Science and Technology in Nanobiopharmaceutics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
  • Fernandes LF; Neuroscience Center, Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
  • Alves MTR; Neuroscience Center, Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
  • Sinisterra R; Department of Chemistry, Institute of Exact Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
  • Bruch GE; Neuroscience Center, Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
  • Santos RAS; National Institute of Science and Technology in Nanobiopharmaceutics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
  • Massensini AR; Neuroscience Center, Department of Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
  • Campagnole-Santos MJ; National Institute of Science and Technology in Nanobiopharmaceutics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Curr Med Chem ; 29(19): 3483-3498, 2022.
Article en En | MEDLINE | ID: mdl-35125076
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Daño por Reperfusión / Isquemia Encefálica / Fármacos Neuroprotectores / Accidente Cerebrovascular / Accidente Cerebrovascular Isquémico Límite: Animals / Humans / Male Idioma: En Revista: Curr Med Chem Asunto de la revista: QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Emiratos Árabes Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Daño por Reperfusión / Isquemia Encefálica / Fármacos Neuroprotectores / Accidente Cerebrovascular / Accidente Cerebrovascular Isquémico Límite: Animals / Humans / Male Idioma: En Revista: Curr Med Chem Asunto de la revista: QUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Emiratos Árabes Unidos